Business Beats Cancer Chester

Business Beats Cancer Annual Dinner guests

Business Beats Cancer Chester

The Next event will be our annual dinner, Thursday 20th November 2025. For more information on how you can get involved, please click on the register your interest link below

Register your interest

Donate to BBC Chester

Business Beats Cancer Chester brings together business leaders to raise vital funds for Cancer Research UK. The Business Beats Cancer Chester board is one of a growing network of boards across the UK. Each board organises an exciting annual fundraising event that brings together businesses in its local area to beat cancer.

What we're funding in the North West

The North West is home to our Manchester Institute, where our work spans the whole spectrum of cancer research, from investigating the molecular basis of cancer to developing new treatments. In 2017, the Paterson building, which housed part of the Cancer Research UK Manchester Institute, suffered a devastating fire. Out of the ashes we've come together with the University of Manchester and the Christie Hospital NHS Foundation Trust to think on a grander scale. In 2023, we opened the doors to our new world-class cancer research facility on the site of the Paterson Building.
As well as the institute we have the Manchester Centre, which delivers world-leading research that accelerates the transition of lab-based discovery to the clinic for the benefit of people affected by cancer. It's also home to one of our RadNet centres of excellence, which together form a network that aims to improve cancer survival by optimising and personalising radiotherapy.
The University of Manchester also plays a central role in our research activity. It forms part of our Lung Cancer Centre of Excellence (along with University College London) and The International Alliance for Cancer Early Detection (ACED). The Lung Cancer Centre of Excellence brings together the unique and complementary strengths of our partner organisations to create a collaborative environment in which integrated lung cancer research can flourish. ACED is a £55 million partnership that brings together world leading researchers from five institutions across the UK and the US to tackle the biggest challenges in early detection and improve cancer diagnosis.  
Finally, the Manchester and Liverpool Experimental Cancer Medicine Centres, which we co-fund the National Institute for Health Research in England, bring together lab scientists and cancer doctors to speed up the flow of ideas and new treatments from the lab to the clinic.